🟢 Alzamend Neuro is trading 5% up today with no confirmed new catalyst

Alzamend Neuro is trading 5.2% up at $1.82; no confirmed new company-specific announcement explains the move.

• A previously announced Phase 1/2A lithium-imaging abstract is scheduled for oral presentation at an ISMRM workshop in Barcelona on September 29 at 1:35 p.m. local time. The announcement predates the move and is not a confirmed fresh catalyst.
• The broader market is mixed, with no clear matching market-wide move.